Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/577| Title: | Atypical fractures associated with bisphosphonate use post-renal transplantation | Authors: | Burke, M. T. Hollett, Peter Gray, Nicholas |
Issue Date: | 2012 | Source: | April 17, (SUPPL. 1), 2012, p. 1-4 | Pages: | 1-4 | Journal: | Nephrology | Abstract: | Bone disease is a major cause of morbidity post renal transplantation. The authors present a case of adynamic bone disease and atypical fractures associated with the use of bisphosphonates following renal transplantation. The uncertain role of parathyroidectomy and bone mineral density scans is also reviewed. 2012 The Authors Nephrology 2012 Asian Pacific Society of Nephrology.Novartis Top 5 Renal Transplant Cases. | DOI: | http://dx.doi.org/10.1111/j.1440-1797.2012.01579.x 517 |
Resources: | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed10&AN=2012220010 | Keywords: | Atypical fractureBisphosphonate;Kidney;Transplant;adult;article;atypical fracture/co [Complication];atypical fracture/di [Diagnosis];atypical fracture/et [Etiology];atypical fracture/si [Side Effect];atypical fracture/su [Surgery];bone density;bone disease/co [Complication];bone disease/di [Diagnosis];bone disease/et [Etiology];bone disease/su [Surgery];bone graft;bone mineral;bone remodeling;bone turnover;calcium blood level;case report;chronic kidney disease/su [Surgery];chronic kidney disease/th [Therapy];computer assisted tomography;conservative treatment;corticosteroid therapy;diabetes mellitus/si [Side Effect];disease course;drug dose increase;drug dose reduction;drug substitution;drug use;drug withdrawal;dual energy X ray absorptiometry;female;femur fracture/co [Complication];femur fracture/di [Diagnosis];femur fracture/et [Etiology];femur fracture/su [Surgery];femur neck;femur subtrochanteric fracture/co [Complication];femur subtrochanteric fracture/di [Diagnosis];femur subtrochanteric fracture/et [Etiology];femur subtrochanteric fracture/su [Surgery];fracture/co [Complication];fracture/di [Diagnosis];fracture/et [Etiology];fracture/si [Side Effect];fracture/su [Surgery];fracture treatment;hemodialysis;hormone substitution;human;hypercalcemia/co [Complication];hypercalcemia/dt [Drug Therapy];hyperphosphatemia/co [Complication];immunosuppressive treatment;kidney graft rejection/co [Complication];kidney graft rejection/dt [Drug Therapy];kidney graft rejection/pc [Prevention];kidney transplantation;lumbar spine;morbidity;nuclear magnetic resonance imaging;open reduction;organ transplantation;osteosynthesis;parathyroid hormone blood level;parathyroid hyperplasia/di [Diagnosis];parathyroid hyperplasia/su [Surgery];parathyroidectomy;pelvis fracture;phosphate blood level;postoperative period;priority journal;secondary hyperparathyroidism/co [Complication];secondary hyperparathyroidism/su [Surgery];stress fracture/co [Complication];stress fracture/di [Diagnosis];stress fracture/et [Etiology];stress fracture/su [Surgery];treatment outcome;alendronic acid/ae [Adverse Drug Reaction];bisphosphonic acid derivative/ae [Adverse Drug Reaction];bisphosphonic acid derivative/dt [Drug Therapy];bisphosphonic acid derivative/iv [Intravenous Drug Administration];calcitriol;calcium carbonate/po [Oral Drug Administration];cyclosporin/cb [Drug Combination];cyclosporin/dt [Drug Therapy];mycophenolic acid 2 morpholinoethyl ester/cb [Drug Combination];mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy];pamidronic acid/ae [Adverse Drug Reaction];pamidronic acid/dt [Drug Therapy];pamidronic acid/iv [Intravenous Drug Administration];parathyroid hormone/ec [Endogenous Compound];parathyroid hormone[1-34];prednisone/ae [Adverse Drug Reaction];prednisone/cb [Drug Combination];prednisone/do [Drug Dose];prednisone/dt [Drug Therapy];prednisone/po [Oral Drug Administration] | Type: | Article |
| Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.